Validation of novel therapeutic approach for leptomeningeal metastases
Ended Project Grant Awarded Last action
- Award ID
- R42CA206744
- Recipient
-
Minnetronix, Inc. UEI MKKQLNN6GSE5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,949,379
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Minnesota, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $637,111 | |
| Amendment | $0 | |
| Amendment | $646,349 | |
| Original award | $665,919 |
Quick answers
Who received award R42CA206744?
R42CA206744 was awarded to Minnetronix, Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2016.
How much is award R42CA206744 worth?
$1,949,379 has been obligated on R42CA206744.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award